ANL
Adlai·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 0
Stock Price Surged Significantly
RSI Oversold
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ANL
Adlai Nortye Ltd.
A biotechnology company focused on cancer treatments
Biological Technology
05/09/2018
09/29/2023
NASDAQ Stock Exchange
123
12-31
Depository Receipts (Ordinary Shares)
c/o PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands
Arnold Pharma is a global clinical-stage biotechnology company focused on discovering and developing innovative cancer therapies for patients with various tumor types.
Arnold Pharma Group Limited was incorporated in the Cayman Islands on May 9, 2018 to facilitate overseas financing activities. The company's day-to-day operations are mainly carried out through subsidiaries operating in the United States and mainland China. Arnold Pharma Group Co., Ltd. started its business in Mainland China in 2004 through Adlai Nortye Biopharma Co., Ltd. Arnold Pharma is a global clinical-stage biotechnology company focused on discovering and developing innovative cancer therapies for patients with various tumor types. Arnold Pharma's mission is to transform a deadly cancer into a chronic, ultimately curable disease. Arnold Pharma is currently leveraging its deep knowledge in cancer biology, as well as significant global R&D and clinical execution capabilities, to develop a variety of innovative anti-tumor drug candidates.
Company Financials
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
